Therefore, we propose as the next step in our research to examine the specific mechanisms behind the pharmacokinetic differences of the representative components of WJW between normal rats and IBS rats from the perspectives of intestinal microbiome and CYP enzymes. The gene discussed is PPIG; the disease is irritable bowel syndrome.